These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 492189)

  • 41. Familial benign hypercalcaemia. Study of a large family.
    Menko FH; Bijvoet OL; Fronen JL; Sandler LM; Adami S; O'Riordan JL; Schopman W; Heynen G
    Q J Med; 1983; 52(206):120-40. PubMed ID: 6310672
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3.
    Sandler LM; Winearls CG; Fraher LJ; Clemens TL; Smith R; O'Riordan JL
    Q J Med; 1984; 53(210):165-80. PubMed ID: 6087399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Angiotensin-converting enzyme and 1,25-dihydroxyvitamin D3 in hypercalcemia of unknown origin].
    Leidig P; Baum HP; Krakamp B; Finke K; Bönner G
    Dtsch Med Wochenschr; 1988 Dec; 113(51-52):2003-6. PubMed ID: 2849536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Brixen K; Mosekilde L
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):713-20. PubMed ID: 18410554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Familial hypocalciuric hypercalcaemia: a review.
    Christensen SE; Nissen PH; Vestergaard P; Mosekilde L
    Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):359-70. PubMed ID: 21986511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Malignancy-associated hypercalcaemia: relationship between mechanisms of hypercalcaemia and response to antihypercalcaemic therapy.
    Ralston SH; Gardner MD; Jenkins AS; McKillop JH; Boyle IT
    Bone Miner; 1987 May; 2(3):227-42. PubMed ID: 2974309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Mechanisms and disturbances of renal functions in so-called idiopathic hypercalcemia].
    Maciejewski J; Fellmann K; Siekierska A; Waligóra A
    Wiad Lek; 1966 Apr; 19(8):655-8. PubMed ID: 5942925
    [No Abstract]   [Full Text] [Related]  

  • 48. [Etidronate per os in subcutaneous fat necrosis with hypercalcemia and nephrocalcinosis].
    Trullemans B; Bottu J; Van Nieuwenhuyse JP
    Arch Pediatr; 2007 Feb; 14(2):170-2. PubMed ID: 17137767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mithramycin treatment of malignant hypercalcaemia.
    Edwards CR; Besser GM
    Br Med J; 1968 Jul; 3(5611):167-8. PubMed ID: 5662551
    [No Abstract]   [Full Text] [Related]  

  • 50. [Dichloromethylene diphosphonate (Cl2MDP) treatment of hypercalcaemia produced from bone metastases (author's transl)].
    Delmas P; Chapuy MC; Vignon E; Briançon D; Charhon S; Meunier PJ
    Nouv Presse Med; 1982 Apr; 11(19):1471-4. PubMed ID: 6210878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of the hypercalcaemia of malignancy with intravenous clodronate.
    Urwin GH; Yates AJ; Gray RE; Hamdy NA; McCloskey EV; Preston FE; Greaves M; Neil FE; Kanis JA
    Bone; 1987; 8 Suppl 1():S43-51. PubMed ID: 2961354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypercalcaemia in patients with newly diagnosed tuberculosis in Malaysia.
    Liam CK; Lim KH; Srinivas P; Poi PJ
    Int J Tuberc Lung Dis; 1998 Oct; 2(10):818-23. PubMed ID: 9783529
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The preliminary experiences of diagnosis and treatment for hypercalcemia crisis--clinical analysis of 23 cases].
    Xing X; Meng X; Zhan Z
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Apr; 16(2):116-21. PubMed ID: 7987937
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum.
    Peacock M
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N87-94. PubMed ID: 12412783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal impairment in hypophosphatasia.
    Bacchetta J
    Arch Pediatr; 2017 May; 24(5S2):5S93-5S95. PubMed ID: 29405941
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nephrocalcinosis in a 2-month-old girl suffering from a mild variant of idiopathic infantile hypercalcemia.
    Zajadacz B; Juszkiewicz A
    Wiad Lek; 2004; 57(11-12):710-2. PubMed ID: 15865256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypercalcaemia in Hodgkin's disease.
    Lambrecht L; Boelaert J; Louwagie A; Criel A; Daneels R; Bouillon R
    Acta Clin Belg; 1986; 41(1):37-42. PubMed ID: 3754677
    [No Abstract]   [Full Text] [Related]  

  • 58. Symptomatic hypercalcaemia in thyrotoxicosis.
    Twycross RG; Marks V
    Br Med J; 1970 Jun; 2(5711):701-3. PubMed ID: 5429653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of glucocorticoids in management of malignant hypercalcaemia.
    Percival RC; Yates AJ; Gray RE; Neal FE; Forrest AR; Kanis JA
    Br Med J (Clin Res Ed); 1984 Aug; 289(6440):287. PubMed ID: 6430440
    [No Abstract]   [Full Text] [Related]  

  • 60. [Neonatal cytosteatonecrosis complicated by major hypercalcemia].
    Kettani AE; Kamal N
    Pan Afr Med J; 2018; 29():86. PubMed ID: 29875967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.